AKYA - Akoya Biosciences Inc Company Value to Earnings Growth Ratio

Brandmark of Akoya Biosciences (AKYA)

Akoya Biosciences strictly adheres to electronics disposal standards and is modernizing its offices. Akoya Biosciences attracts scientists through R&D investments and an innovative culture. An undervalued "rocket" filter based on PEG confirms the investment appeal, where this metric equals 0.00. High barriers to entry are ensured by reagent patents and unique intellectual property in the field of spatial biology.

Akoya Biosciences Inc (AKYA): PEG Multiple from 07/04/2022 to 07/19/2025

Metric breakdowns and analytics for Akoya Biosciences (AKYA)

- price and consensus price forecast:
Market Chart akoyabio.com|AKYA - Consensus Target
- market capitalization statistics:
Market Value Akoya|AKYA - Enterprise Value
- book capitalization information:
Net Assets per Share Akoya Biosciences|AKYA - Book Capitalization|Market Cap to Net Assets Ratio akoyabio.com|AKYA - Cumulative Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Akoya Biosciences|AKYA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio akoyabio.com|AKYA - Company Aggregate Debts|Debts to Book Value Akoya|AKYA - Company Long-Term Debts|Company Short-Term Indebtedness Akoya Biosciences|Interim Coverage Ratio akoyabio.com
- net income and valuation ratios data:
AKYA - Net Profit|Future Profit Akoya Biosciences|AKYA - P/E Multiple|Forward P/E Multiple akoyabio.com|AKYA - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akoya|AKYA - Operating profit before deduction of amortization|Earnings per share for the trailing year Akoya Biosciences|AKYA - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months akoyabio.com|AKYA - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Akoya Biosciences
General company analysis:AKYA - Akoya Biosciences Inc
Finished products of Akoya Biosciences, Inc.

The PEG ratio correlates the current P/E multiple with the earnings per share growth rate, identifying undervalued assets when the value is below one. By analyzing the price-to-earnings ratio relative to the EPS growth forecast, an investor assesses the scaling efficiency of Akoya Biosciences (AKYA), where cost optimization via the outsourcing of board production and global logistics directly impacts net income dynamics and the company's ultimate valuation.

Competing companies

Growth-Adjusted Market Cap to Net Income Abbott Labs|Thermo Fisher Corp - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio GEHC (GE HealthCare Inc.)|Mettler-Toledo International - PEG Multiple|Growth-Adjusted Market Cap to Net Income waters.com WAT|TECH: PEG Multiple|Price/Earnings to Growth Multiple Bruker Corp|Price/Earnings to Growth Multiple AZTA|VREX: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Semler Scientific, Inc. (SMLR)|Price/Earnings to Growth Multiple butterflynetwork.com BFLY|PEG Multiple MLAB (Mesa Labs)|Quantum-Si Inc. (QSI) - Price to Earnings Adjusted for Growth Rate|Nanox - PEG Multiple|QTRX (Quanterix Inc) - Growth-Adjusted P/E Ratio|MASS: PEG Multiple|CV - Growth-Adjusted Market Cap to Net Income|MXCT (MaxCyte) - PEG Multiple|Price/Earnings to Growth Multiple Rapid Micro (RPID)|PEG Multiple SEER|PEG Multiple Hyperfine Medical (HYPR)|Price/Earnings to Growth Ratio FONAR Corporation FONR|Daxor Corp - Price/Earnings to Growth Ratio|MDAI: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio VIVS (Organovo Holdings)|ACON: PEG Multiple|Price to Earnings Adjusted for Growth Rate Cesca Therapeutics (THMO)|Price/Earnings to Growth Ratio Talis Biomedical Corp.|TTOO - Price to Net Income Growth Ratio